Today on Medscape

Top Stories from Across Medicine
 
 

Top Medical News from Across Medscape

  • FDA Approves Lixisenatide (Adlyxin) for Type 2 DiabetesThe latest GLP-1 agonist for the treatment of type 2 diabetes to gain approval in the US is lixisenatide; it's already approved under the brand name Lyxumia in more than 60 countries.

USMLE Quizzes

 

Ask the Experts

 

Columnists

Business of Medicine

  • HPV Vaccines Work, So Why Aren't Doctors Recommending Them?   Many women die each year from preventable cervical cancer, yet doctors aren't urging their younger patients to get vaccinated--possibly to avoid awkward discussions about STDs, an ethicist says.
  • How to Negotiate the Best Raise Possible Physicians may be leery of pressing for better pay or more perks. But doing so the right way could help make a strong case for more money.

Medscape Drugs & Diseases

  • Bariatric Surgery The 2nd Diabetes Surgery Summit (DSS-II) issued global guidelines regarding the benefits and limitations of bariatric/metabolic surgery for type 2 diabetes mellitus.
  • Quiz: COPD Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death in the United States. What do you know about this condition? Test your knowledge with our short quiz.

Advisory Board

 

Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.